PG19 THE COST-EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS ESOMEPRAZOLE IN PEPTIC ULCER BLEEDING- A DECISION-TREE MODEL WITH SPANISH COSTS AND NEW CLINICAL DATA
Abstract
Authors
A Barkun V Adam JJY Sung E Kuipers J Mssner D Jensen RC Stuart JY Lau E Nauclr J Kilhamn H Granstedt B Liljas T Lind